ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000721.1|Tobramycin_2 # 569 # 784 # 1 # ID=1_2;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.681	BGC0000721.1|Tobramycin_2 	569	784	+	Loose	950	22.7126	tcr3	55.0	3002893	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGAGGCGGGGCGCCGGCCGAGGGCGCGCCGGAGTGAGACCGTCGCCCCGGCGCCCCCGCGTCGGCGGGCGGCCGAGATGGCGCGACCCGAGGCTCCTCCTGGTAACAAAGAAAGAAATGCGTGAGCTTCCTCGCGGCGTGTTCCGGCGGCTCGGTGGGGAAAGTGGCTGCTTTCTTTCAGTGGCCGAATTTTCGTGTCCACGGCGTGAATTGTGA	MRRGAGRGRAGVRPSPRRPRVGGRPRWRDPRLLLVTKKEMRELPRGVFRRLGGESGCFLSVAEFSCPRREL	MGMANATSQTGEAVADEAGGPAGFTHRQIITALSGLLLAVLLAALDQTIVSTALRTIGDQLHGQTVQAWVITGYLVSSTIAMPFYGKLSDIYGRKPLYLAAIAVFIVGSAACAMANSMETLAIARVLQGFGGAGLMSLPTAVIADLAPVRERGRYFSYLMMAWVAASVLGPLVGGLFAGAGEILGVTGWRWAFLINVPLGLVALLSVRKALNLPHRRVDHPIDFRGALTLALCLVPLLIVAEEGLDWGWGSARSLTLFAVSLIGLVLFVLAERARGLEAMVPLRLFRRGGITMATAVNFTIGVGIFGTVSTLPLFLQLVQGRSATVAGLVIIPVMTGAIVSQTICAKIIKKWNRYKKPAIVGLGSMAGALLSLSAAGADTPLAVIVVIAAWLGFGIGLSQTVITLAIQSSAPKSELGVANAASGLFRQLGGTSGAAVFMSVLFGVAAGRLDGADPDEAVRRALSDPGSTGGLSASAVDAFTSGFDTMFLVGGLILAVGFLLTFPLRELRDEE	13.87	gnl|BL_ORD_ID|592|hsp_num:0	652			1263	1323	tetracycline
BGC0000721.1|Tobramycin_3 # 1311 # 2276 # 1 # ID=1_3;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.735	BGC0000721.1|Tobramycin_3 	1311	2276	+	Loose	1900	32.3426	MexI	30.68	3000808	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGCCCGTTCCCGCGCCGGGAGAGGCGCTGATCCACCTCGGGTACAACTCGATCTGCGGCAGCGACCTGTCGCTGTACCGGGGCGTCTGGCACGGCTTCAGTTACCCCGTCGTGCCCGGTCACGAGTGGAGCGGCACCGTCGTCGAGGTCAACGGACCCGGCGCCGAGCTGGTCGGCCGCGACGTGGTCGGCGACCTCACCTGCGCGTGCGGCTCCTGCGCGGCGTGCGGGCGGGGGACACCGGTGCTCTGCGAGAACCTCCAGGAGCTGGGGTTCACCCGCGACGGGGCGTGCGCCGAGTACATGACGATCCCGACCGGCAACCTCCACGTGTTGCCGGAGGGCCTGTCGCTGCGGGCGGCCTGCCAGGTGGAGCCGGTCGCCGTCGCCCTGCACGCGGTGTCCACTGTGGGCGTCGAGCCCGGTGAGCGCGTGGCCGTCCTCGGCGCGGGCGGGATCGGCCTGATGCTGATGCAGGTGGCCCGGCAGCGCGGCGGCGTGATCACCACGGTCGGCGAGCCGGTCGCGGAGCGCAGGGCGGTCGCCGCCCAGCTTGGCGCGCGGACGGTGACCACCGGCCGCCCTGGCGAGCTGGCGGAGCTGGTGGCTAAGCACCCCGACCTCACGCCGGACGTCGTGCTGGAGGCCTCCGGCTACCCGGTCGCGGTCCAGGAGGCGATCGAGGTCGTGCGCCCTGGCGGCCGGATCGGGCTCGTGGGGTACCGGGTCGAGGAGGTCGGCCCGATGGCGACCCACCACGTCGCCGTGAAGGCGTTGACGATCAGGGGTTCGTTGGGGCCGGGCGGTCGGTTCCCCGAGGCCATCGACCTGCTCGCGCGGGGAGAGATCGAGGTCGAGCCGCTGCTCAGCCACGAGTTCGCGCTGGACGACCACGCCAGGGCGCTGGACCTCGCGCTGCGTCGCGCCGAGGGCAACGTCCGCTCGTTCTTCAACCTCCGCGCCTGA	MPVPAPGEALIHLGYNSICGSDLSLYRGVWHGFSYPVVPGHEWSGTVVEVNGPGAELVGRDVVGDLTCACGSCAACGRGTPVLCENLQELGFTRDGACAEYMTIPTGNLHVLPEGLSLRAACQVEPVAVALHAVSTVGVEPGERVAVLGAGGIGLMLMQVARQRGGVITTVGEPVAERRAVAAQLGARTVTTGRPGELAELVAKHPDLTPDVVLEASGYPVAVQEAIEVVRPGGRIGLVGYRVEEVGPMATHHVAVKALTIRGSLGPGGRFPEAIDLLARGEIEVEPLLSHEFALDDHARALDLALRRAEGNVRSFFNLRA	MTFTDLFVRRPVLALVVSTLILLLGLFSLGKLPIRQYPLLESSTITVTTEYPGASADLMQGFVTQPIAQAVSSVEGIDYLSSTSVQGRSVVTIRMLLNRDSTQAMTETMAKVNSVRYKLPERAYDSVIERSSGETTAVAYVGFSSKTLPIPALTDYLSRVVEPMFSSIDGVAKVQTFGGQRLAMRLWLDADRLAGRGLTASDVAEAIRRNNYQAAPGMVKGQYVLSNVRVNTDLTNVDDFREMVIRNDGNGLVRLRDVGTVELGAAATETSALMDGDPAVHLGLFPTPTGNPLVIVDGIRKLLPEIQKTLPPDVRVDLAYETSRFIQASIDEVVRTLVEALLIVVLVIYLCLGSLRSVLIPVATIPLSMLGAAALMLAFGFSVNLLTLLAMVLAIGLVVDDAIVVVENVHRHIEEGKSPVAAALIGAREVAGPVIAMTITLAAVYTPIGLMGGLTGALFREFALTLAGAVIVSGVVALTLSPVMSSLLLQAHQNEGRMGRAAEWFFGGLTRRYGQVLEFSLGHRWLTGGLALLVCISLPLLYSMPKRELAPTEDQAAVLTAIKAPQHANLDYVELFARKLDQVYTSIPETVSTWIINGTDGPAASFGGINLAAWEKRERDASAIQSELQGKVGDVEGSSIFAFQLAALPGSTGGLPVQMVLRSPQDYPVLYRTMEEIKQKARQSGLFVVVDSDLDYNNPVVQVRIDRAKANSLGIRMQDIGESLAVLVGENYVNRFGMEGRSYDVIPQSLRDQRFTPQALARQFVRTQDGNLVPLSTVVRVALQVEPNKLIQFDQQNAATLQAIPAPGVSMGQAVAFLDDVARGLPAGFSHDWQSDSRQYTQEGNTLVFAFLAALVVIYLVLAAQYESLADPLIILITVPLSICGALLPLALGYATMNIYTQIGLVTLIGLISKHGILMVEFANELQLHERLDRRAAILRAAQIRLRPVLMTTAAMVFGLVPLLFASGAGAASRFGLGVVIVSGMLVGTLFTLFVLPTVYTLLARNHAEVDKSPRSRQLAEADLLVNKA	31.20	gnl|BL_ORD_ID|4683|hsp_num:0	1647			2217	2475	acriflavine; tetracycline; norfloxacin
BGC0000721.1|Tobramycin_4 # 2436 # 3746 # 1 # ID=1_4;partial=00;start_type=GTG;rbs_motif=GGAG;rbs_spacer=6bp;gc_cont=0.747	BGC0000721.1|Tobramycin_4 	2436	3746	+	Loose	750	41.9726	tet(40)	33.33	3000567	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGTCCCACCCAGCCGCGTCCACCGACCCGCCCACACCCGCGGGTGAGCCGTCCACAGAGGACAGCTCGTCCGACGGGGCCTCCGCGCGGGGCACGGGTTCCCGGAGGACGACGCGGCGCCTGTGCCTGTTCTTCGGGCTGCACGAGCTGGTGCCGTTCTTCCCGCTCTACCCGTTGCTGTTCGCCGACCACGGGCTGTCCACCGCCGGCATCTCGGGTCTGCTGGCCTTCTGGTCGGTCACGGCCTTCGTGCTGGAGGTGCCCTCCGGCGTCCTGGGCGACATGTTCTCCCGCCGCCGGCTGCTCGCCCTCGGCGTCGCCGTGCGCGCCTGCGGGTTCGGCCTGTGGGTCGCCTTCCCGTCGCCGTGGGCCTTCGCGGCGGGGTTCCTGTGCTGGGGCCTGTGCGACGCGTTGACCTCGGGGACGCTGGAGTCGCTGGTCTACGATGAGCTGCGCGCGGCGGGCGCGACCGGGCGGTACGCGGCGGTCATGGGGAGCGGGCGGGCCGTGTCGCTGCTGTCGACGCTCACCGCGATCACGCTGGCCGGGCCGCTGTTCGCGCTCGGCGGCTACCCGGCCGTTGGGGTGGTCAGCCTCGGCAGCGGGCTGGCCTGCGCCCTCGCGGCCCTGTCGTTCTCCGAGCCGCCGAGGGAGCAGGTGGACAGCGAGGGCGGAGGGTGGCGCTGGTACGTGGCCACGTTCCGCGCCGGGGTGTCCGAGGTGCGCGGGGACCGGGTCGTGCTGCGCGCGGTGCTGGTCGCCGCGTCGCTGCACAGCATGACGGCGATCGACGAGTACTTCCCGATGCTGGCCAGGGCCAACGGCGCGTCGACGACGATGGTGCCGGTGCTGGTGGCGGTGACCGTCGTCTGCGCCGCCGTGGGCAGCGGCCTGGTCGGCAGGACCGCGCACGCGCCGTCCGGCGCGCTGGGGCTGGCCCTGTTGGCCTCGGCGGCCCTGCTGGCCGCTGGAGCGTTGAGCGGGCTCCAGTCCGGCATGCTGGCCGTGGGCGTGAGCTTCGGCCTGGTGCAGTGGGCGCTCGTGCTGGCCGACACCCGGCTCCAGGACGCGATCACCGGGCCGGCCAGGGCGACCGTGACCTCCGTGGTCGGGTTCGGCTCCGAGGTGGCCTCGGTCGGCTTCTACCTGGCCGCCGGCGCGGTCTCCACCGTCACCTCCATGTCCACGCTGGTCGCCTGGTTCGCGGTGCCGCTGGTCCTCATCGCGGTGGTCGCGTTCCGGTGGCTGCGCCGGGAGCCGTGTCCCACCGGCCAGGTCCGCCCCGAGCCGGAACCGCGGCGGCGCGACTGA	MSHPAASTDPPTPAGEPSTEDSSSDGASARGTGSRRTTRRLCLFFGLHELVPFFPLYPLLFADHGLSTAGISGLLAFWSVTAFVLEVPSGVLGDMFSRRRLLALGVAVRACGFGLWVAFPSPWAFAAGFLCWGLCDALTSGTLESLVYDELRAAGATGRYAAVMGSGRAVSLLSTLTAITLAGPLFALGGYPAVGVVSLGSGLACALAALSFSEPPREQVDSEGGGWRWYVATFRAGVSEVRGDRVVLRAVLVAASLHSMTAIDEYFPMLARANGASTTMVPVLVAVTVVCAAVGSGLVGRTAHAPSGALGLALLASAALLAAGALSGLQSGMLAVGVSFGLVQWALVLADTRLQDAITGPARATVTSVVGFGSEVASVGFYLAAGAVSTVTSMSTLVAWFAVPLVLIAVVAFRWLRREPCPTGQVRPEPEPRRRD	MFAKNSKAYSVYLLFRFVCSLAVSMSTVLSIVYHLEVVQLDAFQLVLVGTVQEASCFLFEMPTGVVADLYSRRRSVLIGMFLYGLGFLMEGALPWFAPVLLAQVVWGCGDTFITGALEAWIASEEEDKPIDKVFLRGSQMGQIGGVLGVVLGTLLGNINLQMPLILGGSLCLLLGLVMVRIMPETNFSPAIEERQGLLKDFVCLFKLNLGFVKGAPVLLALLAITLCGGLASEGFDRLSTAHFLDDTVIPVIGPLNSVTWFGVISLIGNGLGILASQLLIARMEKKGTVSRTSVVMSTSAGYILFLVLFAVGRSFWFMLLVFLLAGLMRTIKEPVLAAWMNDHVDEKMRATVFSTSGQLDSFGQIIGGPIVGLVAQQVSIPWGLVCTAFLLLPALFLVPVAGKKRD	107.39	gnl|BL_ORD_ID|891|hsp_num:0	945			162	372	tetracycline
BGC0000721.1|Tobramycin_6 # 5114 # 6640 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=5bp;gc_cont=0.739	BGC0000721.1|Tobramycin_6 	5114	6640	+	Loose	750	26.1794	tet(40)	45.83	3000567	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGCTGCTGATCTCAGCGGACGAGGCCGCGCGTCGGACCTACGACGCCTGTGTGGTCGGCAGCGGCGCCTCGGGATCCGTGGCCGCGGCCGTGCTCGCCGAACGGGGGCTGTCCGTGCTCGTCGTGGAGCAGGGCGGCCCGATCCCGCCCGGCGCGGACGTGGAGGACCACGAGGACCCCGACGGGTGGGCGTTCGCGCGTCGCCACGGGCGGTGGACGCGCGACGGCTTCCCGTGGACCGCCATGGCGCTCGGCGGCGGCACCGTGTTCTACGCCGGGATGTCCTACCGCTACCAGGACTCCGACCTGGCCCCGCCCTCGTCGCTGCTCGGCGAGGCCGACTACGACCACTGGCAGGTCGGCCTCGCCGACCTGGAGCCGCACTACGAGTGGATCGAGTACCAGCTCGCGGTGGCCGGGCCGTCCCGGAAGCGGGTGGGGGACTACGTGTTCCCCGTCTACCACCGGCCCAGCCTGCCGCCCACCCCGCCCGGGTTGGCGCTCGCCGAGGGCGCCCGCGCCCTCAACCTGACGCCCCTGCCCACCCCCGTGGCGATCAGCGGGATCCGGGACCGGTTCGGCCCCGGGTGCGCGCAGGCCACGCCCTGCACGTCGTTCTCCTGCCCCACCGGGGCGAAGGCCGACGTCGTCAGCCGGGTCCTCGCCCCGGCCGAGGGCGACGTCTCGGTGCTCGTCCACACCCGGGTCGACCGCCTTGTGGCCTCCGGCTCCCATCGGGTCGACGCCGCCGAGGTGGTCGACCGGGGGACCGGCACGCGCCGGACCCTGCGGGCGCGCCGGTTCCTGGTGGCCGCCAACGCCATCCAGTCCGCCGCGTTGCTGCTCCGGTCGACCAGTCGGCTCGAACCCGACGGCCTGGGCAACGGCAATGGCCTCGTCGGCCGCCACCTGGCGATGAAGAACAGCGTCTACGTGCGGGGAGTCGTGCCGCGCAGGCTTCCCGGGTACACACCGCTGCGGCACCGGTACTCCAGCGTCTGCGTGTTGGACTACCTGACCGGAGAGGAGTTCCCCGACGGCGTCGGCGGCCTGATCCACGAGGCCAACCCGTGGGAGCCGGCGGCCGAGCGCGAGGCCGAGCGCGGCACCGTGCTCCAGGTCGAGTGTCTGCTGGGCGACCGGCCCCAGGCGCGGAACCGGGTGCGGCTGTCCCGCACGCGCGACCGCGACGGCTTTCCCCGCATCGTCCTCGACTACGAGCCCCACCCCGCAGACCTCACGCGGTTGGCCGTGTTGTCCGAGCGCGCCACCGACATCCTCACCAAGGCAGGGGCGATCGACGTGCGGGAGGTGGACACCGCCTACGAGCTGGGCAGCGCCCACCTGCACGGCACGCTGCGCTCCGGCCGCGATCCCCGCACCTCGGTGACCGACCCGTTCGGCCGCCTGCACGGCTACGACAACGTGTGGGCCGTGGACGGCGCGACCTTCCCGTTCGCCGGCAACCCCAACCCCACCCTGACCATCCAGGCCAACGCCCACCGGATCGCGTCCGCGATCGACTGA	MLLISADEAARRTYDACVVGSGASGSVAAAVLAERGLSVLVVEQGGPIPPGADVEDHEDPDGWAFARRHGRWTRDGFPWTAMALGGGTVFYAGMSYRYQDSDLAPPSSLLGEADYDHWQVGLADLEPHYEWIEYQLAVAGPSRKRVGDYVFPVYHRPSLPPTPPGLALAEGARALNLTPLPTPVAISGIRDRFGPGCAQATPCTSFSCPTGAKADVVSRVLAPAEGDVSVLVHTRVDRLVASGSHRVDAAEVVDRGTGTRRTLRARRFLVAANAIQSAALLLRSTSRLEPDGLGNGNGLVGRHLAMKNSVYVRGVVPRRLPGYTPLRHRYSSVCVLDYLTGEEFPDGVGGLIHEANPWEPAAEREAERGTVLQVECLLGDRPQARNRVRLSRTRDRDGFPRIVLDYEPHPADLTRLAVLSERATDILTKAGAIDVREVDTAYELGSAHLHGTLRSGRDPRTSVTDPFGRLHGYDNVWAVDGATFPFAGNPNPTLTIQANAHRIASAID	MFAKNSKAYSVYLLFRFVCSLAVSMSTVLSIVYHLEVVQLDAFQLVLVGTVQEASCFLFEMPTGVVADLYSRRRSVLIGMFLYGLGFLMEGALPWFAPVLLAQVVWGCGDTFITGALEAWIASEEEDKPIDKVFLRGSQMGQIGGVLGVVLGTLLGNINLQMPLILGGSLCLLLGLVMVRIMPETNFSPAIEERQGLLKDFVCLFKLNLGFVKGAPVLLALLAITLCGGLASEGFDRLSTAHFLDDTVIPVIGPLNSVTWFGVISLIGNGLGILASQLLIARMEKKGTVSRTSVVMSTSAGYILFLVLFAVGRSFWFMLLVFLLAGLMRTIKEPVLAAWMNDHVDEKMRATVFSTSGQLDSFGQIIGGPIVGLVAQQVSIPWGLVCTAFLLLPALFLVPVAGKKRD	125.12	gnl|BL_ORD_ID|891|hsp_num:0	945			144	216	tetracycline
BGC0000721.1|Tobramycin_7 # 6757 # 8469 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=8bp;gc_cont=0.720	BGC0000721.1|Tobramycin_7 	6757	8469	+	Loose	900	28.4906	adeH	28.0	3000779	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCGTGTCCTCGGGCTGAACGGCTGGCCCCGCGACTTCCACGACGCGTCGGCGGCCCTGCTCGTCGACGGCCGGATCGCGGCCTTCGCCGAGGAGGAGCGGTTCACACGGAAGAAGCACGGGTACAACACGGCCCCGGTGCAGGCGGCGGCGTTCTGCCTCGCCCAGGCCGGCCTGACCGTGGACGACCTCGACGCGGTCGCGTTCGGCTGGGACCTGCCGGCGATGTACCGCGAGCGACTGGGCGGCTGGCCGCACTCCGACAGCGAGGCGCTGGACATCCTGTTGCCCAGGGACGTGTTCCCCCGGCGCACCGATCCACCGCTGCACTTCGTCCAGCACCACCTGGCCCACGCGGCGAGCGCCTACTACTTCTCCGGCGAGGACCGTGGCGCGGTGCTCATCGTGGACGGCCAGGGCGAGGAGGAGTGCGTGACCCTCGCCCACGCCGAGGGCGGCAAGATCACCGTGCTCGACACGGTCCCCGGCGCGTGGTCCCTGGGGTTCTTCTACGAGCACGTGAGCGAGTACACGGGGCTCGGCGGGGACAATCCCGGCAAGCTCATGGGACTGGCCGCGCACGGGACCACAGTGGACGAGACGCTGTCCGCCTTCGCGTTCGACTCGGACGGCTACCGCCTGAACCTGATCGACCCGCAGGCCCGTGACCCCGAGGACTGGGACGAGTACTCGGTGACCGAGCGGGCGTGGTTCGCCCACCTGGAGCGGATCTACCGGCTGCCGCCGAACGAGTTCGTCCGCCGCTACGACCCGGCCAAGGGGCGGGTCGTCCGGGACACCCGACGGGACCCCTACGAGTACCGCGACCTCGCGGCCACGGCGCAGGCCGCGCTGGAGCGGGCGGTGTTCGGCCTGGCCGACTCGGTGCTGGCCCGCACCGGGGAACGCACCCTGTTCGTCGCTGGGGGCGTGGGCCTCAACGCGACCATGAACGGCAAGCTGCTCACCCGGTCCACTGTGGACAAGATGTTCGTCCCGCCGGTGGCCAGCGACATCGGGGTCAGCCTCGGCGCGGCCGCCGCGGTCGCCGTCGAGCTGGGCGACCGGATCGCGCCCATGGGCGACACCGCGGCGTGGGGGCCGGAGTTCTCCCCCGACCAGGTGCGGGCCGCGCTCGACCGCACCGGCCTGGCCTACCGGGAGCCGGCGAACCTGGAGCGCGAGGTGGCCGCCCTGATCGCCTCCGGCAAGGTGGTGGGCTGGGCCCAGGGGCGGGGCGAGGTCGGCCCCCGCGCGCTGGGGCAGCGCAGCCTGCTCGGCTCCGCGCACTCGCCGACCATGCGCGACCACATCAACCTGCGGGTCAAGGACAGGGAGTGGTGGCGCCCGTTCGCCCCGAGCATGCTGCGGTCGGTCAGCGACCAGGTACTGGAGGTCGACGCCGACTTCCCGTACATGATCATGACGACGAAGGTGCGCGCCGCCTACGCCGAACGCCTGCCGTCGGTGGTGCACGAGGACTGGTCCACCCGGCCGCAGACCGTGACCGAGGCGAGCAACCCGCGCTACCACCGGATGCTCACCGAACTCGGCGACCTCGTCGGCGACCCCGTCTGCCTCAACACCTCGTTCAACGACAGGGGCGAGCCGATCGTGTCCTCCCCGGCCGACGCCCTGCTCACCTTCTCCCGCCTGCCGATCGACGCCCTGGCGGTCGGTCCGTACCTGGTCACGAAGGACCTCCGCCACTAG	MRVLGLNGWPRDFHDASAALLVDGRIAAFAEEERFTRKKHGYNTAPVQAAAFCLAQAGLTVDDLDAVAFGWDLPAMYRERLGGWPHSDSEALDILLPRDVFPRRTDPPLHFVQHHLAHAASAYYFSGEDRGAVLIVDGQGEEECVTLAHAEGGKITVLDTVPGAWSLGFFYEHVSEYTGLGGDNPGKLMGLAAHGTTVDETLSAFAFDSDGYRLNLIDPQARDPEDWDEYSVTERAWFAHLERIYRLPPNEFVRRYDPAKGRVVRDTRRDPYEYRDLAATAQAALERAVFGLADSVLARTGERTLFVAGGVGLNATMNGKLLTRSTVDKMFVPPVASDIGVSLGAAAAVAVELGDRIAPMGDTAAWGPEFSPDQVRAALDRTGLAYREPANLEREVAALIASGKVVGWAQGRGEVGPRALGQRSLLGSAHSPTMRDHINLRVKDREWWRPFAPSMLRSVSDQVLEVDADFPYMIMTTKVRAAYAERLPSVVHEDWSTRPQTVTEASNPRYHRMLTELGDLVGDPVCLNTSFNDRGEPIVSSPADALLTFSRLPIDALAVGPYLVTKDLRH	MVITSKQNWLLSSLMGSLLLAGCSLAPEYQPAKVIVPVKFKESDPKLEDNNWKIAQPADQQTRGEWWRIYNDAQLNELEQQAIAGNQNLKAVAANIQASRALRSAAQAERLPSIDAGFGPTRQKPSPASLGLDDNAHTSAQTLWRAQANVSYELDLFGRVASSVNAATADLQQQEALYQSALLALQADVAQGYFLIRQLDTEQAIYNRTIKLLGETRDLMQLRFKNGLVSELDVSRAQTELATAQTTALNIARNRASAEHALAVLLGKPPADFNLAVQPLTANSIRLPAGLPSTLLERRPDIAAAERAMAADNARIGIARAAFFPKLSLTGALGYESSSLSELGKWSSRTFLLGPVAGTILSLPLFDGGQRKAGVAQARAAYEESVANYRQTVLNAFREVENGLSDQRILDQQIQAQNQALSSSRHANQLSHLRYREGAISYLDVIDSDRTILQQEQLAAQLKGSQIIASINLIRALGGGWSS	118.01	gnl|BL_ORD_ID|493|hsp_num:0	542			192	342	tetracycline
BGC0000721.1|Tobramycin_10 # 10001 # 11161 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=5bp;gc_cont=0.732	BGC0000721.1|Tobramycin_10 	10001	11161	+	Loose	1200	29.6462	LRA-13	35.71	3002484	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	class C LRA beta-lactamase; class D LRA beta-lactamase	ATGCAGACCACCACCATCACCATGGGAGACGTCCAGTACCCGTACCGGCTGGGCACCGGCTGCGTCGACGGGATCGTCACCCGGCTCGGCGAGCTGGAGGCCAGCCACTACCTCGTGCTGTGCGACGCGACCGTCGCCGAGCTGTACGGCCACGACCTCGCCGCGCGGCTGCGCCGCTCGGCCGGTCCCGCCAGCGTCCTGACGCACCCGGCCGGCGAGGAGCACAAGGGCCTCGGCACGCTGGACACGCTCGCCGACGCCGCCCTCCACGCGGGCGTCGACCGGCGCGGCGTGGTCGTCGCCCTGGGCGGCGGCGTCACCGGCAACATCGCGGGCCTGCTCGCCGCCCTGCTGTTCCGCGGCATCCGCCTGGTCCACGTGCCGACGACCGTCGTGGCCATGCTCGACTCGGTGCTGTCGCTGAAGCAGGCCGTCAACGCGCAGGTGGGCAAGAACCTCGTCGGCACCTTCTACCCGCCGGTGGAGGTGCTGGCCGACACCGCCATGCTGGGCACCCTCCCGGTCAGGGAGATCCGCTCGGGCCTGTGCGAGGTCGTGAAGAACGCGCTGGCCATCCGGCCCAGCATGATCGACTTCCTGGCGGCCGAGCTGAGACCGGACGGGCGGTACGCCGACGACGTCCTGCGCTGGATGATCGACGAGAGCGTCGCGGCCAAGGCCCAGGTCACCGAGCACGACAAGTACGAGCGGCGCGAGGGCCTGGTCCTGGAGTACGGCCACACCGTCGGCCACGCGCTGGAGCACGCCTCGCACGGCGCGGTGTCCCACGGCGCAGGGGTCGGCGTGGGCATGGTCGCCGCGGCCGAGGTCGCCCGCCGGCTCGGGCACGTCGACGCCGACCTCGTCGAGCTGCACAGGGAGCTGGTCGGCAAGGTCGGCGTCGCGACGACGCTGCCGGCCGACGTGCCGACCGAGGAGATCACCTACCGGCTCGGCTTCGACAACAAGCGGGGCTACCAGCCGCTGCCCGCCGACCACTACGCCATGGTCCTGCTCGCCGACGTCGGCCAACCCCTGTACCAGGACGGGCTGCCGCTCACGCCGGCGCCCCGCGCCCTCGTGGACGAGGTCGTCCGGGAGCTGGCCGACGCCCCGTCCCGGATCGGGGCGTCCGTGGGTTCCGCCGGAGGTGCGTCGTGA	MQTTTITMGDVQYPYRLGTGCVDGIVTRLGELEASHYLVLCDATVAELYGHDLAARLRRSAGPASVLTHPAGEEHKGLGTLDTLADAALHAGVDRRGVVVALGGGVTGNIAGLLAALLFRGIRLVHVPTTVVAMLDSVLSLKQAVNAQVGKNLVGTFYPPVEVLADTAMLGTLPVREIRSGLCEVVKNALAIRPSMIDFLAAELRPDGRYADDVLRWMIDESVAAKAQVTEHDKYERREGLVLEYGHTVGHALEHASHGAVSHGAGVGVGMVAAAEVARRLGHVDADLVELHRELVGKVGVATTLPADVPTEEITYRLGFDNKRGYQPLPADHYAMVLLADVGQPLYQDGLPLTPAPRALVDEVVRELADAPSRIGASVGSAGGAS	MNFRHIVMAALCGLAWTPAIHATEVCIAIAEAGTGAVLVQRGDCQRQVTPASTFKIAISLMGYDSGFLKDAHAPKLPFRPGYVDWRPSWREPTDPAKWMSDSVVWYSQQVTKSLGMQRFADYTRNFKYGNADVSGDAENDGLSMSWISSSLRISPLEQLAFLDKIVNRRLGVSAHAYDMTAQLTKFDQPPAGWRINGKTGAASGYGWYVGWASKGSRTFVFAHLMQRDATQPQDVSAGVLARDEFLKELPGLMIKDMVDRAVQPLMKKYDIPGMAVAVTDNGKNYFFNYGLASRETGQAVTSHTLFEIGSLSKTMAATLTSYAQVNGQLALTDTVSRHMPKLRGGGFDKISLLNLGTHTAGDFPMQVPDHIETYEQLMEYYKNWKPGVAAGGARTYSNLTVGLLGIITAQSMGMPFAEAMENRLFPQLGMHHSYINVPAAEMKNYAQGYNQANAPVRINPAVLATEAYGVKTDAADLIRFVDANMGLVKLDEKLQRAVTGTHTAYFKTGELTQDLIWEQYPAASKLDRMLAGVSEKMVFESNPATRLAPPMPPQADVLINKTGSTGGFGAYALFNPGKKTGIVMLANKSYPGAERVTAAWHILDQLDQR	63.38	gnl|BL_ORD_ID|1764|hsp_num:0	1912			225	336	
BGC0000721.1|Tobramycin_11 # 11158 # 12375 # 1 # ID=1_11;partial=00;start_type=GTG;rbs_motif=GGAG;rbs_spacer=7bp;gc_cont=0.743	BGC0000721.1|Tobramycin_11 	11158	12375	+	Loose	500	28.8758	CARB-21	28.05	3003176	protein homolog model	n/a	n/a	penam	antibiotic inactivation	CARB beta-lactamase	GTGAACTCTCCGCTCAACCAGCCACCGCACAAGTCACTGAACGAGCCACTGGGCAAGTCACTGAACGAGCCACTGGGCAAGTCACTGAACGAGCCGCTGGGCAAGTCACTGAACGAGCCGCTGGGCAAGTCACTGAACGAGCCGCTGGGCGTCGCCGTGGTCGGCGCGGGGTTCATGGGAGGCGTCCACGCCGAGGTGTTCGCCGAGCACCCGAGGGCGCGGCTCGCCGCGGTCTGCGACCTCGACCGGGGCGCGGCGCGCGAGCTGGCGGGGCGGTTCGCCGTCGAGACCGTCACCGACGACCTCGACAGCGTCCTGTCCGACGACCGGATCGGGCTGGTCGTGGTGACGACGCCGAACGCCCTGCACGCCGAGCAGGCCGCACGGGCGTTGCGGGCCGGCCGGCACGTGCTGGTCGAGAAGCCCCTCGCGCTCACCTCCGACGAGATCCGCGGCCTGCTCCGACTGGCCGACGAGCGCGGACTGGTGCTCGCGCACGGCAGCAACTTCGTGCACAGCCCCAAGTTCCGGCGGGTCCGCGAGCTGGTCGCCGACGCCGACGCGTTCGGCCGGCCGCACCTGGCGCGGGTCGTCGTGCGCAACGGGGGACCGGACTCCGGGTGGTGCCTGGACCCGGCGCTCGCCGGCGGCGGCGTCCTGCTCGACCTCGGCTGCCACGCGGTCGAGATCTGCCGGTGGCTGCTGGGCGGCGCGGAGGTCCGCGCCGTCACCGCGCGCAGCCAGCGGGTGCGGCCCCGCGCCGGGCGGGTCGAGGACCAGGCGACGCTGCTGCTGGAGTTCGCCGACGGCGCGCTGGGCCAGTGCGACGTCTCCTGGGCCTGTCCCGGCGGTGAGGAGATCACGACCGAGGTGCTGGGCACCAGCGGTCGGGCCGGCGCCGACCTGTGGGCCGGGATGGGCGTGCACGCCTTCTCCGAACGGGGCTTCGCCAGCGTGTGGGAGCCGAACCAGGGGTGGGTCCGCCCGGAGTGGGAGTGGGTCAGGGCGAGCGGCTACACCCACCAGGACCACGCCGTGGTCGAGGCGGTCCTGGACGGCACACCCCTGCCGCACTCCGCCGTCGAGGCGTGGACCTCGGCCAGGGTGCTGGAGGCGGCGGCGGAGAGCGCGGCCACCGGCCGCACCGTCGAGCTGGCCCCGTCCCCGAACGGCCACCCTGTGCCCGACGCCGTCCGGGGAGGCGACCGTGTCCACTGA	MNSPLNQPPHKSLNEPLGKSLNEPLGKSLNEPLGKSLNEPLGKSLNEPLGVAVVGAGFMGGVHAEVFAEHPRARLAAVCDLDRGAARELAGRFAVETVTDDLDSVLSDDRIGLVVVTTPNALHAEQAARALRAGRHVLVEKPLALTSDEIRGLLRLADERGLVLAHGSNFVHSPKFRRVRELVADADAFGRPHLARVVVRNGGPDSGWCLDPALAGGGVLLDLGCHAVEICRWLLGGAEVRAVTARSQRVRPRAGRVEDQATLLLEFADGALGQCDVSWACPGGEEITTEVLGTSGRAGADLWAGMGVHAFSERGFASVWEPNQGWVRPEWEWVRASGYTHQDHAVVEAVLDGTPLPHSAVEAWTSARVLEAAAESAATGRTVELAPSPNGHPVPDAVRGGDRVH	MVRVFTRYSLLNIAKVRIKTKRTKNTRMKKLFLLVGLMVCSTVSYASKLNEDISLIEKQTSGRIGVSVWDTQMDERWDYRGDERFPLMSTFKTLACATMLSDMDSGKLNKNATARIDERNIVVWSPVMDKLAGQSTRIEHACEAAMLMSDNTAANLVLNEIGGPKAVTLFLRSIGDKATRLDRLEPRLNEAKPGDKRDTTTPNAMVNTLHTLMEDNALSYESRTQLKIWMQDNKVSDSLMRSVLPKGWSIADRSGAGNYGSRGISAMIWKDNYKPVYISIYVTDTDLSLQARDQLIAQISQLILEHYKES	130.65	gnl|BL_ORD_ID|834|hsp_num:0	906			27	243	
BGC0000721.1|Tobramycin_12 # 12365 # 13654 # 1 # ID=1_12;partial=00;start_type=GTG;rbs_motif=GGAG;rbs_spacer=6bp;gc_cont=0.718	BGC0000721.1|Tobramycin_12 	12365	13654	+	Loose	700	52.373	LpsB	24.29	3005051	protein homolog model	n/a	n/a	peptide antibiotic	reduced permeability to antibiotic	Intrinsic peptide antibiotic resistant Lps	GTGTCCACTGAGGACAGTGACAGACCGGTGCGGCGGCGGGGCGGCGTGCTGGCGCTCACCCCGTTCTTCCTCTACCCCGAGTACCAGGACTGCTGGTCGGCCCGGTTCGACTCGATGGGCGGGATGCACCTGCTGGTGCGGGCGCTCGTGGAGGAGATGGCCGGCAGGGGCGTCCCGCACCGCGTGCTCACCATGGCCCCGCCCGGCGTGCCCAGGGACCTGGCCATCGCCCGCAACGTCACCGTCCACGCGCGACGCCTCCCGGTGTTGCCGATCCCGTCCCAGTTGGAGGGGTACTTCGGGCTGGTCGGGGCGTGGGCCAAGGGGAGCCTGCTGTGGGTCCTGCGGAACCGGAGGCGGCTGCGGCGGGAGATCTCCCTGGTGCACGCCCACTGCGACGGGTCGGGCTCGGCGCCGTTCTACGGCTGGCTCATCGCGCGGGCGCTGGGCGTGCCGCTGGTGGCGCAGATCCACTCCAGCCGGTTCCTGAGCCAGCACCCCACGACGTTGTGGGAACGGGTCACCGACCCGGCCGCGAAGTGGGCGGAGCGGTTCACCGTCCGCAACGCGGCGGCGGTGCTGATGCTCACCGAGAAGGCCCGCACCGAGATGCGGGACGCGGCGGCGCTGGACCCCCGGCGCGTCCACCGGCTGGCCTACCTGGCCAGCGACCGCTTCGCCGAGGGCGACACCGAGGAGCGGAGGACCGAGATCAGGCGGCGCTTCGGCCTGGACACCGGCCAGCCCGTCGTCCTCTACGTCGGGCGGATCGCGGCCGAGAAGGGCGTGGAGTTCTTCGTCGAGGCCGCCGCCGAACTGCGGCGGCGCGGGCGTAACTGCCGGTTCCTCGTCGCGGGGGACGGCCCGACCCGCCAGGAGATCGAGAAGCTGGCCGAGGACAGGGGCGTCGCCGACCGGATCACGATCACCGGTTTCCTGCCGCACGAGCTGATCCCCTCGGTGATGGCATTGTCCCAGCTCGTGGTCCTGCCCTCCCGGTACGAGGAACTGGGCATCGTGATCCTGGAGTGCATGAGCATGCGCCGGCCGATCGTCGCGCACGACGTCAACGGCGTGCACAAGCTCATCGAGCATGGCAGGACCGGGCTGTTGGTGCCGCCGTTCGACACGCCCGCGATGGCCGACGCCATCGAGGCGCTGCTGGACGACCCGGAGCTGCGGGAGCGGATCGCCGAGACCGCCGCCCCGCTGCCGTCCGCGAAGTACTCGCTGACCACGGCGGCGGACCAGCTCACGGACATCTACCGGGAGCTGGGCGTATGCGTCTGA	MSTEDSDRPVRRRGGVLALTPFFLYPEYQDCWSARFDSMGGMHLLVRALVEEMAGRGVPHRVLTMAPPGVPRDLAIARNVTVHARRLPVLPIPSQLEGYFGLVGAWAKGSLLWVLRNRRRLRREISLVHAHCDGSGSAPFYGWLIARALGVPLVAQIHSSRFLSQHPTTLWERVTDPAAKWAERFTVRNAAAVLMLTEKARTEMRDAAALDPRRVHRLAYLASDRFAEGDTEERRTEIRRRFGLDTGQPVVLYVGRIAAEKGVEFFVEAAAELRRRGRNCRFLVAGDGPTRQEIEKLAEDRGVADRITITGFLPHELIPSVMALSQLVVLPSRYEELGIVILECMSMRRPIVAHDVNGVHKLIEHGRTGLLVPPFDTPAMADAIEALLDDPELRERIAETAAPLPSAKYSLTTAADQLTDIYRELGVCV	MKVMQLLPELNSGGVERGTLEIARALVAQGHQSLVVSNGGRLVSQLEAEGSTHLTLPIHKKSLSSLWQIRPLRQLIEEHQPDIVHVRSRVPAWLTHFALRKIPANKRPHLISTVHGFYSVNRYSAIMTQAEKVIAVSDSVVKYITGHYKNCPPQDIIRIYRGIDPAAFPHNYQPSAQWFNQVFNDFPELENKFLLCLPGRITRLKGHESLIELMQQLHSQYPQLHAVVVGGADVKKQAYLSELQNTIQSKGLADKITFVGHRSDIREWLAFSDIVLSLSNQAETFGRTALEALSVGTPVIGWNRGGVAEILSHVYPQGLVEAENEKALLEIVKHHIEQPQTVAPVTMFSLKDMCDQTLELYQSVLK	117.21	gnl|BL_ORD_ID|2781|hsp_num:0	3793			594	1092	colistin A; colistin B; defensin
BGC0000721.1|Tobramycin_14 # 14427 # 15677 # 1 # ID=1_14;partial=00;start_type=GTG;rbs_motif=GGAG;rbs_spacer=5bp;gc_cont=0.708	BGC0000721.1|Tobramycin_14 	14427	15677	+	Loose	300	27.7202	dfrD	32.65	3002866	protein homolog model	n/a	n/a	diaminopyrimidine antibiotic	antibiotic target replacement	trimethoprim resistant dihydrofolate reductase dfr	GTGACCTCGGAACTCGCGTTGTTCGGCGGCACACCCGTGCGCACCGAGCCCTTCCCCGACGGCCCCCGCTTCCGCGAGCGGGACCTGGAGCGCATCCGGGAGGTGCTGGAGTCCGGCAGCCTCGGCGGCATCCCCTTCCCGAACCGCACCCACCGGGCGTTCGCCGAGCAGTTCTGCGGCCGGCTCGGCGCCCGGCACGGCGTGCTGGTCGCCAACGGCACCGTGAGCCTGTCCGTGGCCCTGCGGGCCCTCGGCGTGCACGCCGGTGACGAGGTGATCACCACCGGCTACACGTGGATGGGCACGGCCGCGTCCATCGTGCACATCAACGCCGTGCCGGTGCTCGTGGACATCGACCCGAACACCTGGTGCATCGACCCGGCGGCCGTCGAGGCGGCCATCACGCCCAGGACCAGGGCGATCGTGCCGGTGCACCTGGCCAACCAGATCGCCGACCTCGACGCGCTGCTGGAGATCGCCAGGAAGCATGACCTGGTCGTGCTGGAGGACTGCGCCCACGCGCACTTCGCCGAGTGGCGCGGCCGCTGCGTCGGCACGCACGGCGACGCCGGCAGCTTCAGCTTCGAGAGCAGCAAGATCATGACCTCCGGCGAGGGCGGATTCCTGGTCAGCGGGGACGAGACCACCCACCACCGGGCCATGTCGCTGGTCAACTGCGGGCGCAAGGAGGAGGGCTACGACTCCTTCGAGGGCCGCATGCTCGGCTGGAACAACCGGGCCACCGAGTTGCAGGCCGCCTTCCTCATCGGACAGGTCGAACAGCACGACGAGCTGCACGCCCAGCGGAAGTCCAACGTGGAGCTGCTGACCAAGGGGCTCACCGAGATCGGCGGCTTCACGCCGGTCGGCGACGACGACCCCAGGGTGACGCGCCGGCAGTACTACGAGGTGCTCTACCGCTTCGACCCCGAGCAGTGGGCGGGCGTGCACCGCGACCGGGTGCTGGAGGCCCTGCTCGCCGAGGGCGTCGAGTTCGAGGGCATCACCTTCTACCCGCCGCTGCACCGGGACTCGCTGTTCACGGTCAGCGCCGAGGACTGGCCGATGATCCGCGACCGGTACGGCGACCGCATGGGGCCGGAGGACTTCCACCTCCCGGTCTCCGAGCGGGCCGCCTACGACGAGTCGGTGTGGGTCCACCACTCCCTGCTCACCGGCCCGGCCACGGACGTCGACCAGATCCTGGAGGCCGTGGCGAAGGTCCGCCGCAACGTCGACGCCCTGCGCTGA	MTSELALFGGTPVRTEPFPDGPRFRERDLERIREVLESGSLGGIPFPNRTHRAFAEQFCGRLGARHGVLVANGTVSLSVALRALGVHAGDEVITTGYTWMGTAASIVHINAVPVLVDIDPNTWCIDPAAVEAAITPRTRAIVPVHLANQIADLDALLEIARKHDLVVLEDCAHAHFAEWRGRCVGTHGDAGSFSFESSKIMTSGEGGFLVSGDETTHHRAMSLVNCGRKEEGYDSFEGRMLGWNNRATELQAAFLIGQVEQHDELHAQRKSNVELLTKGLTEIGGFTPVGDDDPRVTRRQYYEVLYRFDPEQWAGVHRDRVLEALLAEGVEFEGITFYPPLHRDSLFTVSAEDWPMIRDRYGDRMGPEDFHLPVSERAAYDESVWVHHSLLTGPATDVDQILEAVAKVRRNVDALR	MKISLIVAMDKKRVIGKDNDIPWRISSDWEYVKNTTKGHAIILGRKNLQSIGRALPDRRNIILTRDKNFNFKDCEIAHSIEAAFKLCENEEEVFIFGGEQIYVMFLPYVEKMYVTKIHHEFEGDTFFPVVNFDDWKEVSVEKGIKDEKNPYDYYFHIYERIR	256.79	gnl|BL_ORD_ID|426|hsp_num:0	474			357	480	trimethoprim
BGC0000721.1|Tobramycin_15 # 15736 # 16107 # 1 # ID=1_15;partial=00;start_type=GTG;rbs_motif=GGAG;rbs_spacer=5bp;gc_cont=0.780	BGC0000721.1|Tobramycin_15 	15736	16107	+	Loose	500	24.6386	APH(6)-Ia	29.27	3002657	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(6)	GTGAACCCGACGAGGCAGGACCTTCGGACCGATCCCCCGCGCCACGGCGACGGCCTCCACGACGCGGTGGACCTGTTGCGCAGGGCCATGGCGCTGGTGCTCGCCCACACCGACCAGTGGGACGCGCTCGGCGCGGCGAGCGTCGCGGCCGTCGAGGCCGCGCTGGAGATGGTCGCGGCCAACGCCGGGACGGCCACGGGGAACGGCGCGGCGCCCGCGCCCGCCGGACCCCGAGGCCGGCGGACCGAGGACATCCAGCGGGCCGTCGACAGCGCCAGGGCCGCGGTCGTCGCGAGCACGTTCGCCCTTCGCGAGGCGGCCGATGAGGAACGCCGCCGGCGGCAGACGCCTCCGCCGCGCGCGGGAGCCTGA	MNPTRQDLRTDPPRHGDGLHDAVDLLRRAMALVLAHTDQWDALGAASVAAVEAALEMVAANAGTATGNGAAPAPAGPRGRRTEDIQRAVDSARAAVVASTFALREAADEERRRRQTPPPRAGA	MSSSDHIHVPDGLAESYSRSGGEEGRAWIAGLPALVARCVDRWELKRDGGVRSGEASLVVPVLRADGTRAALKLQMPREETTAALIGLRAWGGDGMVRLLDHDEESSTMLLERLDGSRTLASVEDDDEAMGVLAGLLNRLHSVPAPPGLRGLGEIAGAMVEEVPSAVDSLADPEDRSRLRGWASAVAELVGEPGDRVLHWDLHYENVLAAEREPWLAIDPEPLVGDPGFDLWPALDTGWERIEATGDARRVVRRRFDLLTESLELDRGRAAGWTLARLLQNTLWDIEDGLTAIAPSQIAVAEALAKP	40.07	gnl|BL_ORD_ID|1382|hsp_num:0	1500			276	507	streptomycin
BGC0000721.1|Tobramycin_16 # 16336 # 17586 # 1 # ID=1_16;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=9bp;gc_cont=0.740	BGC0000721.1|Tobramycin_16 	16336	17586	+	Loose	700	55.8398	LpsB	29.17	3005051	protein homolog model	n/a	n/a	peptide antibiotic	reduced permeability to antibiotic	Intrinsic peptide antibiotic resistant Lps	GTGCGTGTTCTCCGGCTCACCCCGTTCTTCCACCACGACTGCGTCACCTCGTGGCCGGCCGAGTTCGACGCGGTCGGCGGGATGCAGTTGCAGATCCTGCGGCTGTCCCGCGAGCTGGCCCGGCGCGGCGTGCGCCAGCAGGTGCTCACGCTGGGCTTCCCCGGCCTGCCCCGGGTGCGGGTCGACTCGCCGAACCTGGTCGTGCGGATCACCAGGGCCCCGCTGCCCCGGCTGCGGTCGGAGCTGACCGGCCTGGTCGGGCTCAACCAGGCGTGGCTGGTCGCCGCGCTGGCCGCGTGCGTGCGGCTCAGGCGCACCTGGCGCCCCGACCTGGTCCACGTGCACGCCGACGGCCAGCTCTGGGCGTTGCTGGCGGGACCGGCCGCGTCCCGCGTGCTCGGCGTGCCCTACTGCGTGACGCTGCACTGCTCGCGCCTGTCGGTGTACCAGCCCATGTCGTGGATCGACCAGCTCCAGCACCGGCTGGTCGTCGCGGCGGAGAAGTGGGCGCTGCGCGGGGCCTCCGGCGTGTCGACCCTGACCGACCGCACCGCGTCGGTGGTCGCCTCCGCGCTCGGGGTGGGCGCGGAGGACGTCGACGTGGTCCCCGACTCGGTGGACACGTCGTCCACTGTGGACAGAGCAGAGGGGCGCGTGCTGCTGGAGAAGCTGGGCGTGCCGTCCGACCACGAGGCCGTCGGCTACGTCGGCCGCGTCGCGCACGAGAAGGGCTGGCCCGACCTCGTGCGCGTGGCCGGCGCGCTGTCCGACCGGAAGGCGACCTTCCTGGTCGTCGGGGACGGGCCGCAGAGCGGGCGCATGCGCGACGAGGTCGCCGCCGCCGGCCTGTCCGACCGGTTCCTGTTCACCGGGTTCCTGCCCCATCACGACATCCCGGCGGTCATGGCCGGTCTGGACGTGCTCGTGATGCCGTCGCGGCACGAGGAGCTGGGCGGGAGCGCGCTGGAGGCGATGCTGGCGGGAACGCCCGTGGCCGCCTACGCCGTGGGTGGGCTGCGGGACACCGTGGGCCACGTGACGCCGTCGCTGCTCGTGCCTCCCGGCGACGTCACGGCGCTCGCGGAGGCCGTTCGTGGTGTGCTCGACGACCCGCGGCCCCACCGCGACCAGGTGGCGGCCGGCCGTTCCTGGCTGACCGACCTCTTCGACGGCGGTGCCGCCGCGCGTCGGGTGATCGCCCACTATGAGCGTGTCCTCAGTGGAACCGCCCGTCTCCGCCCTCAGGAATAG	MRVLRLTPFFHHDCVTSWPAEFDAVGGMQLQILRLSRELARRGVRQQVLTLGFPGLPRVRVDSPNLVVRITRAPLPRLRSELTGLVGLNQAWLVAALAACVRLRRTWRPDLVHVHADGQLWALLAGPAASRVLGVPYCVTLHCSRLSVYQPMSWIDQLQHRLVVAAEKWALRGASGVSTLTDRTASVVASALGVGAEDVDVVPDSVDTSSTVDRAEGRVLLEKLGVPSDHEAVGYVGRVAHEKGWPDLVRVAGALSDRKATFLVVGDGPQSGRMRDEVAAAGLSDRFLFTGFLPHHDIPAVMAGLDVLVMPSRHEELGGSALEAMLAGTPVAAYAVGGLRDTVGHVTPSLLVPPGDVTALAEAVRGVLDDPRPHRDQVAAGRSWLTDLFDGGAAARRVIAHYERVLSGTARLRPQE	MKVMQLLPELNSGGVERGTLEIARALVAQGHQSLVVSNGGRLVSQLEAEGSTHLTLPIHKKSLSSLWQIRPLRQLIEEHQPDIVHVRSRVPAWLTHFALRKIPANKRPHLISTVHGFYSVNRYSAIMTQAEKVIAVSDSVVKYITGHYKNCPPQDIIRIYRGIDPAAFPHNYQPSAQWFNQVFNDFPELENKFLLCLPGRITRLKGHESLIELMQQLHSQYPQLHAVVVGGADVKKQAYLSELQNTIQSKGLADKITFVGHRSDIREWLAFSDIVLSLSNQAETFGRTALEALSVGTPVIGWNRGGVAEILSHVYPQGLVEAENEKALLEIVKHHIEQPQTVAPVTMFSLKDMCDQTLELYQSVLK	113.66	gnl|BL_ORD_ID|2781|hsp_num:0	3793			594	1020	colistin A; colistin B; defensin
BGC0000721.1|Tobramycin_17 # 17577 # 18053 # -1 # ID=1_17;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=9bp;gc_cont=0.660	BGC0000721.1|Tobramycin_17 	17577	18053	-	Loose	550	26.5646	OHIO-1	43.75	3006956	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	OHIO beta-lactamase	GTGGACGGTTCCGGTGTCGAGGTGGACTGGTTGACGCGGTCAGCGGCGTCATCAGGGACTCAAGCGCGGCCGCCCGGTTCCACTGAGGACACGCTCGTGGTGCGCGACCACCCGACGCACACCGCGCCCCACCGAACGCCGCCTCGTTGTGCCGACAGCCGCCCGGGAGGACTCACGGATGACCGGGGCGACGGATTCTTCCCCTACTCGTCGACTGTGTCCGTTCACTGCGATGGCGTTCCAGCCTCCCGACCCAGTCACGAGCGCGACAGAGATGCCGATGTGCACGACATGGGCGATCACCAAGGCGCGTGTGGTCCGCCACGCGGCGAGCGCGACGAGTCTGGAGCCGGACTGACATCCGGACAGAAGCGCACTCCGTCTCGAATGAGGGGCGGTGTCGGCGCAGTAGGAGACCGCGAACCCACAGGAAACGTCGGTGAGATCGGAGTACGAAACACACCGTCCTATTCCTGA	MDGSGVEVDWLTRSAASSGTQARPPGSTEDTLVVRDHPTHTAPHRTPPRCADSRPGGLTDDRGDGFFPYSSTVSVHCDGVPASRPSHERDRDADVHDMGDHQGACGPPRGERDESGAGLTSGQKRTPSRMRGGVGAVGDREPTGNVGEIGVRNTPSYS	MRYFRLCIISLLATLPLRVHAGPQPLEQIKLSESQLSGSVGMIEMDLARPGTLTAWRADERFPMMSTFKVVLCGAGLARVDAGDEQLERKIHYRRQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAANLLLPAVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTARSMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGRLIRSVLPAGWFIADKTGAGERGARGIVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIAGALIEHWQR	55.24	gnl|BL_ORD_ID|3711|hsp_num:0	4781			141	237	
BGC0000721.1|Tobramycin_18 # 18472 # 18636 # 1 # ID=1_18;partial=00;start_type=GTG;rbs_motif=GGAG;rbs_spacer=10bp;gc_cont=0.685	BGC0000721.1|Tobramycin_18 	18472	18636	+	Loose	400	23.0978	tetB(P)	56.25	3000195	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	GTGGTCGGCTACGAGGTCAAGCCCGCGCGACCCGGCAGGGGGAGAAGGTATGCCGGCCTGTGTTTCGTTGCTGACGAAACACAGGCCGTGGTCCAGCAACTCGTCTATGCGGGGCCGGTGGCCCCACCGGGACCGCTGGCCCCGTCCGGACGTCAGGACCTCTGA	MVGYEVKPARPGRGRRYAGLCFVADETQAVVQQLVYAGPVAPPGPLAPSGRQDL	MKKIINIGIVAHVDAGKTTITENLLYYSGAIKSVGRVDLGNTQTDSMELERKRGITIKSSTISFNWNNVKVNIIDTPGHVDFISEVERSLNSLDGAILVISGVEGIQSQTRILFDTLKELNIPTIIFVNKLDRIGANFNKVFEEIKKNMSNKVVRLQEVYDVGSKAVYIKKLFDTCIINDDAINVLSDLDEAFLERYIGGIEPDKEEIQEKLSLYAREGSLYPVFCGAAAIGLGIEDLLDGICSYFPFASNDCESDLSGVVFKIERTSKNEKKVYVRLFGGKISVRDKIQVPNKEIAEKVKKINRLENGGVVEAQRIEAGDIGILYGLTSFQVGDVIGISNDKIKNISIAKPALKTTISAIDKEKNPELFKALTLLAEEDPLLAFAMNDIDKEIYVNLFGEVQMEILSSMLDDLYGIKVEFSNIETIYKETPKGFGASIMHMQEDLNPFWATVGLEIEPAGRGEGLRYISNVSVGSLPKSFQNAIEEAVIKTSKQGLFGWEVTDVKVTLSCGEFFSPASTPADFRNVTPMVFMEALYKAQTVLLEPLHEFELKIPQNALSKAVWDLETMRATFDNPIVIGDEFSIKGLIPVENSKEYKMKIASYTEGRGMFVTKFYGYKEASAEFSKARKKTTYDPLNKKEYLLHKLNAIRD	8.28	gnl|BL_ORD_ID|737|hsp_num:0	804			1356	1404	tetracycline; doxycycline; minocycline; chlortetracycline; demeclocycline; oxytetracycline
BGC0000721.1|Tobramycin_19 # 18655 # 19887 # -1 # ID=1_19;partial=00;start_type=GTG;rbs_motif=GGAG;rbs_spacer=7bp;gc_cont=0.715	BGC0000721.1|Tobramycin_19 	18655	19887	-	Loose	275	43.8986	vanE	24.64	3002907	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; Van ligase	GTGAACAACGAACTCGTCGTCTTCGTCAACGTCCGTCGCACGCATCTGGAGCGGGGTGCGGTGTTCGAGGCCGCGCACCGCCTCGGCTACGGCGTCGCACTGCTCGCCGACGCGGTGCCGGAGGGTTTACCTCGCGGGATCGTGCGGACCGTGGTGCGACTGGACACCCGGGACGAGGCGGCGGTGCACGCGGCGGTCGACGAGATCGCGGCGGAACACCGGATCGCCGCCGTGCTGGGCTGGTCGGAGCGCGACGTGACCACGGTCAGCGGGATCGCCCAGCGGCTCGGGCTGCCGGGCGTCTCCCCCGGCGCGGCCCGGCTGGCCCGCAACAAGTACCTGATGCGGGAGGCGGTGGCCGAACACCACCCGCACCTGGTCCCCCGGTTCGCGCGGGTCACCGACTGGTCGGACCTGTCGCGCGCGGTGGAGCTGGTCGGTTTCCCCGCCGTGCTCAAGCCCACGTCCTCGTCAGGCAGCCGGGGCATCTTCGTGATCGACGGCCCTGCTGGCCTGCGTCCCGCGTTCGACCGGCTGATGGACCTGACGGCGACCACGGAGACCCGCCACGAGCTGATCTACGAGGAGTTCCTGCACGGCACGGAGCACAGTGTCGAGGGATTCGTCCATTGTGGACAGATCCACGTCGTCGGCGTCATCGACAAGCGCACGACCGAGCCCTTCCGGCTGGAACTCGCGCACCTGCACCCGAGCGCGCTGCCCGCCGACCGGCTCGACGCCGTCCACCGGCTCACGGCCGACGTGGTGTCCGCGTTGGGGCTGGACGACTGCGCCTTCCACCTGGAATGCATGGTTGCCCCGGACGGCGGGGTGAGACTCGTGGAGATCGGGGCAAGGGGTGGCGGGGACTTCATCGCCTCGCACCTGGTCGGGCTGGCCACCGGCCGGTCGTTCGTCGAGAACGCGATCCGGGTCGCGACCGGTCGTCCCCCGCTGGACGCCGCCGGGCCGCCCCTGTGGGCGTGTGTGCGCAAGATCCTGACCGACCGGGTCGGAACCCTCACCGGCTACGCCGGTCTCGACGACGCCTGCCGCGTGCCCGGCGTGCGCCACCTGGTGATCGAGCAACCCGTGGGCGCCGAGATCACCCAGCCACCCGTGGACTTCAAGTCGTGCATCCTGGGCGCGGTGATCACGGTGGGCGATTCGGCGGAGGCGGCGGAGGGGTCGGCCGAGCAGGCCGCCGCCCTGGTCCGCGCCGACATCTCCTGA	MNNELVVFVNVRRTHLERGAVFEAAHRLGYGVALLADAVPEGLPRGIVRTVVRLDTRDEAAVHAAVDEIAAEHRIAAVLGWSERDVTTVSGIAQRLGLPGVSPGAARLARNKYLMREAVAEHHPHLVPRFARVTDWSDLSRAVELVGFPAVLKPTSSSGSRGIFVIDGPAGLRPAFDRLMDLTATTETRHELIYEEFLHGTEHSVEGFVHCGQIHVVGVIDKRTTEPFRLELAHLHPSALPADRLDAVHRLTADVVSALGLDDCAFHLECMVAPDGGVRLVEIGARGGGDFIASHLVGLATGRSFVENAIRVATGRPPLDAAGPPLWACVRKILTDRVGTLTGYAGLDDACRVPGVRHLVIEQPVGAEITQPPVDFKSCILGAVITVGDSAEAAEGSAEQAAALVRADIS	MKTVAIIFGGVSSEYEVSLKSAVAIIKNMESIDYNVMKIGITEEGHWYLFEGTTDKIKKDRWFLDESCEEIVVDFAKKSFVLKNSKKIIKPDILFPVLHGGYGENGAMQGVFELLDIPYVGCGIGAAAISMNKIMLHQFAEAIGVKSTPSMIIEKGQDLQKVDAFAKIHGFPLYIKPNEAGSSKGISKVERKSDLYKAIDEASKYDSRILIQKEVKGVEIGCGILGNEQLVVGECDQISLVDGFFDYEEKYNLVTAEILLPAKLSIDKKEDIQMKAKKLYRLLGCKGLARIDFFLTDDGEILLNEINTMPGFTEHSRFPMMMNEIGMDYKEIIENLLVLAVENHEKKLSTID	116.48	gnl|BL_ORD_ID|1478|hsp_num:0	1617			321	933	vancomycin
BGC0000721.1|Tobramycin_20 # 19956 # 20936 # -1 # ID=1_20;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.734	BGC0000721.1|Tobramycin_20 	19956	20936	-	Loose	420	26.5646	adeN	30.0	3000559	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; lincosamide antibiotic; carbapenem; cephalosporin; tetracycline antibiotic; rifamycin antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic; penem	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGTGTCCCGTTCCCGGCCCGGGAGCCTGGCCCTCGGCCTGGCTCTCGGGGCCGCGGGGGCCGTGGCGATGGGCAGCTCGGCCCCCGCGTTGAAGCTGCTCGCCAGGACCGAGCTGTCCCCGGTGAACGTCATCCAGGTGCGCACGGTCGTCGGCGCGCTGGCCCTGTTGACGGCGGCCCTGCTGCTGCGGCGGGGGCGGTTGCGGATCCGGCCGGGTGACTGGTGGCTGGTGGTGCTGTACGGGGTGGTGACGCTGGCGGTCAACCAGGTCGTCTACACCGTCGCCCTGTCCCGGATCCCGGTCGGGATCGCCCTGCTGCTGGAGTACCTGTCGCCGGTGCTCGTGGCGCTGTGGGTGCGGTTCGTGCAGCGCAAGCACCTCTCCGGCCTGCTGTGGGTGGGGATCGCGGTGGCGTTGTGCGGCCTGGCGTTGATCAGTCAGGTGTGGACGTCGTTCGCCCTGGACGGCGTGGGCGTGCTGTTCGGCCTGCTGGCCGCGGCCACCCTCGCCGGGCGGTTCCTCCTGGCGGAACGGGGGCTGCGGGACTACGACCCGTTGGTGATGGCGACCTGGGGCACCTGCCTCGGCGCGGTCGCGCTCACCCTCGCCGGGGTGGTGGCCCCGTTCCCGTTCCACGTCCTCGGGGAGGTCAGCGCGGTCGGCGGGGTGGACGTGCCGGTGTGGCTGCTCGCGCTCTGGGTGGGGCTGGTCGGCATGGCGGGCGCGATCCTGCTCAGCGTCACGGCGCAGCGGTCGATCCCGCCCACGTCGGCGAGCCTGGTCGCGACGCTGGAGATCGTGGTCGGCGGCGTGCTGGCCATGCTGGTGCTCGGCGAGCGGCTCGGCGCGGTGCAGATGGTGGGCTCGGTGGTGATGTTGGCTGGCATCGTCATCGCCCAGGTCGCGGTGGCGCGTCGGAACACGGCGGCGGTCGCGGCCACGGCCCCGGAACTCCTGCCGACGCGGTCGGCGAGCTGA	MVSRSRPGSLALGLALGAAGAVAMGSSAPALKLLARTELSPVNVIQVRTVVGALALLTAALLLRRGRLRIRPGDWWLVVLYGVVTLAVNQVVYTVALSRIPVGIALLLEYLSPVLVALWVRFVQRKHLSGLLWVGIAVALCGLALISQVWTSFALDGVGVLFGLLAAATLAGRFLLAERGLRDYDPLVMATWGTCLGAVALTLAGVVAPFPFHVLGEVSAVGGVDVPVWLLALWVGLVGMAGAILLSVTAQRSIPPTSASLVATLEIVVGGVLAMLVLGERLGAVQMVGSVVMLAGIVIAQVAVARRNTAAVAATAPELLPTRSAS	MHDPVLESHHLVCEKPQTRRGIERRLALLLSATELFLEKGYDAVSLDDIVNHAGGSKTSIYKYFGNKDGLFTAICDYRREMFFKDICIAFQPEQTSLKDYLIQTLIRFYKPFIQPEHIAFLRLVIEQTQCNATLSQYLYEKCALDVQNTIAQALLISHQSGEITCTSPDHSSLMYFGILRDIEWRMIMGMPLPPNETEVIDYINYCVDIFLKGHHKV	150.23	gnl|BL_ORD_ID|1737|hsp_num:0	1880			288	435	tetracycline; rifampin; imipenem; trimethoprim; chloramphenicol; ticarcillin
BGC0000721.1|Tobramycin_21 # 20936 # 21160 # -1 # ID=1_21;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.751	BGC0000721.1|Tobramycin_21 	20936	21160	-	Loose	500	24.2534	TEM-149	45.71	3001016	protein homolog model	n/a	n/a	monobactam; cephalosporin; penam; penem	antibiotic inactivation	TEM beta-lactamase	TACTTCGTCAGCGCCCTGGTGCGGTCGGACCTGACCGAGGCCGAGTTCCTGGCCGCGGCGGAGCGGGCCGGGGTGCGGCTCTCCCGGGGATCGGCGTTCTTCCCCGACGAGCGCCTGCCCGCCGGGTCGCTGTTCCTCCGGTTGCCGTTCCAGGCGTTGTCACTGGAGGCGTTCCGGCGCGGCGCGCGGGCGCTGGCCGACGTGGTGGCGCGGCGGGTCCGGTGA	YFVSALVRSDLTEAEFLAAAERAGVRLSRGSAFFPDERLPAGSLFLRLPFQALSLEAFRRGARALADVVARRVR	MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTTPAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGVRGSRGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW	25.87	gnl|BL_ORD_ID|1242|hsp_num:0	1355			651	756	ampicillin
